Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer

Meiying Zhang, Xiaoyun Li, James G. Herman, Aiai Gao, Qian Wang, Yuanxin Yao, Fangfang Shen, Kunlun He, Mingzhou GuoClinical 2024 · DOI

Abstract

NRIP3 was frequently methylated in both colorectal adenomatous polyps and CRC. The methylation of NRIP3 may potentially serve as an early detection, late-onset, and poor prognostic marker in CRC. NRIP3 is a potential tumor suppressor. NRIP3 methylation is a potential synthetic lethal marker for combined PI3K and ATR/ATM inhibitors.
BibTeX
@inproceedings{zhang2024methylation,
  author = {Meiying Zhang and Xiaoyun Li and James G. Herman and Aiai Gao and Qian Wang and Yuanxin Yao and Fangfang Shen and Kunlun He and Mingzhou Guo},
  title = {{Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer}},
  booktitle = {Clinical},
  year = {2024},
  doi = {10.14309/ctg.0000000000000682},
}

Loading related content...

Figure